Cargando…
Cognitive Disorders in Patients with Multiple Sclerosis
INTRODUCTION: Multiple sclerosis (MS) is a chronic, inflammatory, (auto) immune disease of the central nervous system (CNS). Cognitive disorders are found in over 50% of patients. AIM: The aim of the study was to determine the distribution of cognitive disorders in people with MS. METHODS: The prosp...
Autores principales: | Sehanovic, Aida, Smajlovic, Dzevdet, Tupkovic, Emir, Ibrahimagic, Omer C., Kunic, Suljo, Dostovic, Zikrija, Zoletic, Emina, Pasic, Zejneba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AVICENA, d.o.o., Sarajevo
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780783/ https://www.ncbi.nlm.nih.gov/pubmed/33424448 http://dx.doi.org/10.5455/msm.2020.32.191-195 |
Ejemplares similares
-
Contributing Factors to the Quality of Life in Multiple Sclerosis
por: Sehanovic, Aida, et al.
Publicado: (2020) -
HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON’S DISEASE
por: Ibrahimagic, Omer C., et al.
Publicado: (2016) -
Comment on an article: “COVID-19 disease will cause a global catastrophe in terms of mental health: A hypothesis”
por: Ibrahimagić, Omer Ć., et al.
Publicado: (2020) -
COMMENT ON AN ARTICLE: “Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19“
por: Ibrahimagić, Omer Ć., et al.
Publicado: (2020) -
Post-Stroke Depression
por: Ibrahimagic, Omer C., et al.
Publicado: (2019)